Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Pleural Diseases 2Mesothelioma, Malignant 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Lymphoid Interstitial Pneumonia 1

Interventions

Nivolumab 2Gefitinib 2Biopsy 2vandetanib 1linrodostat 1ficlatuzumab 1durvalumab 1X-Rays 1Trioxsalen 1Rhinoplasty 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Phototherapy 1Photochemotherapy 1Pemetrexed 1Optical Imaging 1Methods 1Metformin 1Ipilimumab 1Independent Medical Evaluation 1Immunohistochemistry 1Gemcitabine 1Educational Status 1Dihematoporphyrin Ether 1Cetuximab 1Carboplatin 1CTLA-4 Antigen 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoid Interstitial Pneumonia × Trioxsalen × Clear all
NCT02068157 2017-10-11

Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer

Roswell Park Cancer Institute

Phase 2 Terminated
3 enrolled 8 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡